Business
11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome Mapping (OGM). The session revealed how OGM can offer a new standard for detecting and characterizing structural variants (SVs) across cancer, including its unprecedented resolution in rare and heterogeneous cancers. Presentations also described how OGM is i
About this update from Bionano Genomics, Inc.
[{"type":"image","alt":"Bionano Genomics","displaySize":"","headline":null,"caption":"Bionano Genomics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ylN8_Gs3_qAPxed5dOQIGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1","width":300,"height":61}},"lazy":false},{"type":"text","content":"SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome Mapping (OGM). The session revealed how OGM can offer a new standard for detecting and characterizing structural variants (SVs) across cancer, including its unprecedented resolution in rare and heterogeneous cancers. Presentations also described how OGM is increasingly recognized, including by the US Food and Drug Administration (FDA), for its ability as a leading technique for highly sensitive analysis of genome integrity for development of cell and gene therapies such as stem cell therapy and gene editing in the biotechnology and pharmaceutical industries.","length":806,"tagName":"p"},{"type":"text","content":"Attendance at Symposium 2026 continues to grow, now with more than 1,150 registered participants from 73 countries across 6 continents, making Symposium 2026 the single largest global event dedicated to OGM and Bionano solutions this year. The call for posters ended on Day 2, but submissions were continuing to roll in and like the oral presentations, they underscore how OGM can enable scientists, clinicians, and industry researchers to uncover complex genomic events often missed by conventional cytogenetics, fluorescence in-situ hybridization (FISH), or sequencing.","length":571,"tagName":"p"},{"type":"text","content":"11 presenters from leading academic, clinical, and industry centers across Europe and the U.S., including Alka Chaubey, PhD, FACMG, Bionano’s chief medical officer, who opened the day by highlighting OGM’s ability to deliver unbiased, comprehensive, genome-wide structural variant detection across both cancer and engineered cell line applications, providing ...